Advertisement
Videos
Advertisement

Speedier OKs In Sight For Cancer Drugs

Thu, 06/14/2012 - 6:37am

A novel trial design using neoadjuvant treatment to monitor response may accelerate the way cancer drugs are approved for early-stage disease, as this exclusive InFocus report outlines.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading